RxDoctor Payments DataLook up a doctor →

Thanh Truong, DO

Internal Medicine · Wichita, KSNPI 1225009616

Payments from drug & device makers

$27,632in general payments, 2019–2025

Across 1,961 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$3K
  • Amgen$3K
  • AstraZeneca$2K
  • Lilly USA, LLC$2K
  • Pfizer$2K
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)309$2,750
Novo Nordisk249$2,673
Amgen(2 entities)122$2,566
AstraZeneca63$2,098
Lilly USA, LLC194$1,915
Pfizer209$1,759
Johnson & Johnson90$1,036
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC55$1,029
Supernus Pharmaceuticals, Inc.58$914
GSK55$910
Amarin Pharma, Inc.50$780
Boehringer Ingelheim37$726
Sanofi-aventis U.S. LLC46$670
Gilead20$575
Abbott32$541
Phathom Pharmaceuticals, Inc.11$479
Dexcom, Inc.14$428
Eisai Inc.28$332
Vanda Pharmaceuticals Inc.7$319
Sumitomo Pharma America, Inc.17$315
Idorsia Pharmaceuticals US Inc8$306
Otsuka America Pharmaceutical, Inc.7$297
Radius Health, Inc.19$295
Astellas Pharma US Inc13$285
Biohaven Pharmaceuticals, Inc.27$277
Bayer36$253
Esperion Therapeutics, Inc.17$240
Sunovion Pharmaceuticals Inc.24$227
Teva Pharmaceuticals USA, Inc.19$206
E.r. Squibb & Sons, L.L.C.9$205
Biohaven Pharmaceutical Holding Company Ltd.22$188
Mylan Specialty L.p.5$162
Ironshore Pharmaceuticals Inc.2$159
Novartis10$148
Hologic Sales And Service, LLC3$136
Jazz Pharmaceuticals Inc.1$125
Apellis Pharmaceuticals, Inc.1$122
Takeda Pharmaceuticals U.S.A., Inc.7$101
Lundbeck LLC6$95
Almatica Pharma LLC4$90
Globus Medical2$84
Corcept Therapeutics5$82
Merck5$77
Nevro Corp.3$77
Daiichi Sankyo Inc.5$70
Medtronic2$60
Arbor Pharmaceuticals, Inc.4$54
Insulet Corporation2$44
Axsome Therapeutics, Inc.3$41
Antares Pharma, Inc.2$32
Shire North American Group Inc2$28
Biogen2$28
Currax Pharmaceuticals LLC1$25
Xeris Pharmaceuticals, Inc.1$21
Cranial Technologies, Inc1$19
Paratek Pharmaceuticals, Inc.1$16
Nestle Healthcare Nutrition Inc.1$16
IBSA Pharma Inc.1$15
Edwards Lifesciences1$15
Neos Therapeutics, LP1$14

How this compares

$27,632 in reported general payments places this provider in the 95th percentile of 705 internal medicine providers in Kansas.

See all internal medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$112,073
Medicare patients
241
Services billed
1,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →